Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Catalyst Grant: SPOR Innovative Clinical Trials (iCT)

University of Calgary

$98,312.00

Developing a Provincial Learning Healthcare System: An Innovative Clinical Trial to Optimize Safe and Effective Use of Human Albumin Solutions

EF 2018-19

Résumé
Healthcare systems need to more consistently incorporate findings from research into patient care. Gaps between what we know through research and what we do in daily care of patients (knowledge-practice gaps) result in underuse of helpful tests and treatments and overuse of unhelpful ones. Given the amount of research that needs to be incorporated into patient care, and the limited success existing methods have had doing so, new methods for closing these knowledge-practice gaps are needed. This is especially important for patients admitted to intensive care units (ICUs) where multiple expensive, potentially risky tests, and treatments are used to save lives. Decision-makers for ICUs in Alberta have asked us to develop new methods for improving the use of helpful tests and treatments and reducing the use of the unhelpful ones for patients admitted to ICUs. In response to this challenge, we have designed a system composed of key personnel and organizations within Alberta that is capable of more efficiently using helpful tests and treatments and stopping unhelpful ones. We refer to this as a learning healthcare system. However, before we can incorporate this learning healthcare system into our current healthcare system, many of its components require testing and evaluation. The project described in this application proposes to test one component of our system by trying to efficiently decrease unnecessary use of an unhelpful treatment provided to patients admitted to ICUs in Alberta. The treatment is prescription of a blood product called albumin to patients that need intravenous fluids. Research clearly shows that albumin is not helpful for most patients, but costs 40 time the amount of the alternative treatment (standard intravenous fluids). For most patients, its use unnecessarily exposes patients to blood products and constitutes unnecessary healthcare spending. Albumin is thus an excellent treatment to use as the test case for our learning health care system.
Programme
Catalyst Grant: SPOR Innovative Clinical Trials (iCT)
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
398761
Name
Niven Daniel
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Catalyst Grant SPOR Innovative Clinical Trials
Projecttitle
Developing a Provincial Learning Healthcare System: An Innovative Clinical Trial to Optimize Safe and Effective Use of Human Albumin Solutions
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$98,312
Cihrequipment2
$0
Programname2
Catalyst Grant: SPOR Innovative Clinical Trials (iCT)
Keyworddelim
Adoption; Albumin; De-Adoption; Implementation Science; Innovative Clinical Trial; Low-Value
Abstract
Healthcare systems need to more consistently incorporate findings from research into patient care. Gaps between what we know through research and what we do in daily care of patients (knowledge-practice gaps) result in underuse of helpful tests and treatments and overuse of unhelpful ones. Given the amount of research that needs to be incorporated into patient care, and the limited success existing methods have had doing so, new methods for closing these knowledge-practice gaps are needed. This is especially important for patients admitted to intensive care units (ICUs) where multiple expensive, potentially risky tests, and treatments are used to save lives. Decision-makers for ICUs in Alberta have asked us to develop new methods for improving the use of helpful tests and treatments and reducing the use of the unhelpful ones for patients admitted to ICUs. In response to this challenge, we have designed a system composed of key personnel and organizations within Alberta that is capable of more efficiently using helpful tests and treatments and stopping unhelpful ones. We refer to this as a learning healthcare system. However, before we can incorporate this learning healthcare system into our current healthcare system, many of its components require testing and evaluation. The project described in this application proposes to test one component of our system by trying to efficiently decrease unnecessary use of an unhelpful treatment provided to patients admitted to ICUs in Alberta. The treatment is prescription of a blood product called albumin to patients that need intravenous fluids. Research clearly shows that albumin is not helpful for most patients, but costs 40 time the amount of the alternative treatment (standard intravenous fluids). For most patients, its use unnecessarily exposes patients to blood products and constitutes unnecessary healthcare spending. Albumin is thus an excellent treatment to use as the test case for our learning health care system.
Competitiondate
201811
Approvedterm2
1 yr 0 mth
Pinamesdelim
Niven, Daniel; Bagshaw, Sean M; Fiest, Kirsten M; Petermann, Lisa; Stelfox, Henry T
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $98,312~ $0~